NeuBase Therapeutics Inc

-0.01 (-3.20%)
7:29:48 PM EDT: $0.43 +0.05 (+13.76%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

NeuBase Therapeutics Inc Stock, :NBSE

350 Technology Drive, Suite 421, Pittsburgh, Pennsylvania 15219
United States of America
Phone: +1.412.763.3350
Number of Employees:


NeuBase Therapeutics is a pre-clinical stage biopharmaceutical company that develops gene silencing therapies with its synthetic antisense oligonucleotides. It also provides a platform that focuses on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy, and Familial Parkinson's Disease, among others.